Roldán, F.L.; Izquierdo, L.; Ingelmo-Torres, M.; Lozano, J.J.; Carrasco, R.; Cuñado, A.; Reig, O.; Mengual, L.; Alcaraz, A.
Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma. Cancers 2022, 14, 3754.
https://doi.org/10.3390/cancers14153754
AMA Style
Roldán FL, Izquierdo L, Ingelmo-Torres M, Lozano JJ, Carrasco R, Cuñado A, Reig O, Mengual L, Alcaraz A.
Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma. Cancers. 2022; 14(15):3754.
https://doi.org/10.3390/cancers14153754
Chicago/Turabian Style
Roldán, Fiorella L., Laura Izquierdo, Mercedes Ingelmo-Torres, Juan José Lozano, Raquel Carrasco, Alexandra Cuñado, Oscar Reig, Lourdes Mengual, and Antonio Alcaraz.
2022. "Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma" Cancers 14, no. 15: 3754.
https://doi.org/10.3390/cancers14153754
APA Style
Roldán, F. L., Izquierdo, L., Ingelmo-Torres, M., Lozano, J. J., Carrasco, R., Cuñado, A., Reig, O., Mengual, L., & Alcaraz, A.
(2022). Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma. Cancers, 14(15), 3754.
https://doi.org/10.3390/cancers14153754